140 related articles for article (PubMed ID: 16541251)
1. QSAR modeling of AT1 receptor antagonists using ANN.
Su Q; Zhou L
J Mol Model; 2006 Sep; 12(6):869-75. PubMed ID: 16541251
[TBL] [Abstract][Full Text] [Related]
2. Modeling the antileishmanial activity screening of 5-nitro-2-heterocyclic benzylidene hydrazides using different chemometrics methods.
Garkani-Nejad Z; Ahmadi-Roudi B
Eur J Med Chem; 2010 Feb; 45(2):719-26. PubMed ID: 19959260
[TBL] [Abstract][Full Text] [Related]
3. Discovery of Potent Antihypertensive Ligands Substituted Imidazolyl Biphenyl Sulfonylureas Analogs as Angiotensin II AT1 Receptor Antagonists by Molecular Modelling Studies.
Sharma MC
Interdiscip Sci; 2015 Sep; 7(3):221-32. PubMed ID: 26188391
[TBL] [Abstract][Full Text] [Related]
4. Comparative chemometric modeling of cytochrome 3A4 inhibitory activity of structurally diverse compounds using stepwise MLR, FA-MLR, PLS, GFA, G/PLS and ANN techniques.
Roy K; Pratim Roy P
Eur J Med Chem; 2009 Jul; 44(7):2913-22. PubMed ID: 19128860
[TBL] [Abstract][Full Text] [Related]
5. QSAR modeling of mono- and bis-quaternary ammonium salts that act as antagonists at neuronal nicotinic acetylcholine receptors mediating dopamine release.
Zheng F; Bayram E; Sumithran SP; Ayers JT; Zhan CG; Schmitt JD; Dwoskin LP; Crooks PA
Bioorg Med Chem; 2006 May; 14(9):3017-37. PubMed ID: 16431111
[TBL] [Abstract][Full Text] [Related]
6. Structure-activity relationship study of some triazolinone based compounds with antagonistic balanced activity on angiotensin II receptor subtypes AT1 and AT2. A three-dimensional quantitative structure-activity relationship investigation.
Pandya T; Chaturvedi SC
Arzneimittelforschung; 2005; 55(5):265-70. PubMed ID: 15960425
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Multiple Linear Regressions and Neural Networks based QSAR models for the design of new antitubercular compounds.
Ventura C; Latino DA; Martins F
Eur J Med Chem; 2013; 70():831-45. PubMed ID: 24246731
[TBL] [Abstract][Full Text] [Related]
8. QSAR studies on 3-(4-biphenylmethyl) 4, 5-dihydro-4-oxo-3H-imidazo [4, 5-c] Pyridine derivatives as angiotensin II (AT1) receptor antagonist.
Sharma MC
Interdiscip Sci; 2015 Jun; 7(2):113-28. PubMed ID: 26215494
[TBL] [Abstract][Full Text] [Related]
9. Hybrid docking-QSAR studies of DPP-IV inhibition activities of a series of aminomethyl-piperidones.
Amini Z; Fatemi MH; Gharaghani S
Comput Biol Chem; 2016 Oct; 64():335-345. PubMed ID: 27570070
[TBL] [Abstract][Full Text] [Related]
10. QSAR studies of bioactivities of 1-(azacyclyl)-3-arylsulfonyl-1H-pyrrolo[2,3-b]pyridines as 5-HT6 receptor ligands using physicochemical descriptors and MLR and ANN-modeling.
Goodarzi M; Freitas MP; Ghasemi N
Eur J Med Chem; 2010 Sep; 45(9):3911-5. PubMed ID: 20547432
[TBL] [Abstract][Full Text] [Related]
11. QSAR of antitrypanosomal activities of polyphenols and their analogues using multiple linear regression and artificial neural networks.
Rastija V; Masand VH
Comb Chem High Throughput Screen; 2014; 17(8):709-17. PubMed ID: 25092383
[TBL] [Abstract][Full Text] [Related]
12. Identifying structural features related to the biological activity of a series of AT1 antagonists from fragment-based drug design.
da C Silva D; Maltarollo VG; Honorio KM
Protein Pept Lett; 2014 Jun; 21(6):542-9. PubMed ID: 24779772
[TBL] [Abstract][Full Text] [Related]
13. Molecular docking, 3D-QSAR and structural optimization on imidazo-pyridine derivatives dually targeting AT1 and PPARg.
Zhang J; Hao QQ; Liu X; Jing Z; Jia WQ; Wang SQ; Xu WR; Cheng XC; Wang RL
Oncotarget; 2017 Apr; 8(15):25612-25627. PubMed ID: 28445965
[TBL] [Abstract][Full Text] [Related]
14. Linear and nonlinear modeling of antifungal activity of some heterocyclic ring derivatives using multiple linear regression and Bayesian-regularized neural networks.
Caballero J; Fernández M
J Mol Model; 2006 Jan; 12(2):168-81. PubMed ID: 16205958
[TBL] [Abstract][Full Text] [Related]
15. CoMFA and CoMSIA studies of angiotensin (AT1) receptor antagonists.
Datar P; Desai P; Coutinho E; Iyer K
J Mol Model; 2002 Oct; 8(10):290-301. PubMed ID: 12483229
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, pharmacological evaluation and in silico ADMET prediction of novel substituted benzimidazole derivatives as angiotensin II-AT1 receptor antagonists based on predictive 3D QSAR models.
Vyas VK; Gupta N; Ghate M; Patel S
SAR QSAR Environ Res; 2014; 25(2):117-46. PubMed ID: 24598006
[TBL] [Abstract][Full Text] [Related]
17. Measurement and ANN prediction of pH-dependent solubility of nitrogen-heterocyclic compounds.
Sun F; Yu Q; Zhu J; Lei L; Li Z; Zhang X
Chemosphere; 2015 Sep; 134():402-7. PubMed ID: 25985098
[TBL] [Abstract][Full Text] [Related]
18. Structure-response relationship in electrospray ionization-mass spectrometry of sartans by artificial neural networks.
Golubović J; Birkemeyer C; Protić A; Otašević B; Zečević M
J Chromatogr A; 2016 Mar; 1438():123-32. PubMed ID: 26884139
[TBL] [Abstract][Full Text] [Related]
19. Exploring QSARs for inhibitory effect of a set of heterocyclic thrombin inhibitors by multilinear regression refined by artificial neural network and molecular docking simulations.
Ramírez-Galicia G; Garduño-Juárez R; Correa-Basurto J; Deeb O
J Enzyme Inhib Med Chem; 2012 Apr; 27(2):174-86. PubMed ID: 21635208
[TBL] [Abstract][Full Text] [Related]
20. QSAR modeling of aromatase inhibitory activity of 1-substituted 1,2,3-triazole analogs of letrozole.
Nantasenamat C; Worachartcheewan A; Prachayasittikul S; Isarankura-Na-Ayudhya C; Prachayasittikul V
Eur J Med Chem; 2013 Nov; 69():99-114. PubMed ID: 24012714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
